Indian Journal of Medical and Paediatric Oncology

LinksSchließen

Referenz

André F, O’Regan R, Ozguroglu M. et al
Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial.

Lancet Oncol 2014;
15 (06) 580-591

Bibliographische Angaben herunterladen

Aufrufen in: